|
|
 |
|
Viewing report
|
|
|
|
Contraception Market Report 2011
Key Note Publications Ltd, Nov 2011, Pages: 82
This Key Note Market Report examines the various forms of contraception available in the UK market. It covers oral contraceptives, condoms, implants, injections, caps and diaphragms, and intra-uterine products. For the purpose of this report, the market is divided broadly into four sectors: hormone-based products, barrier products, intra-uterine products and other methods. Each sector is further broken down into a variety of sub-sectors.
As most contraceptives are supplied and subsidised by the NHS, while also being regarded by many consumers as essential rather than discretionary purchases, the market for contraceptives escaped the recent economic downturn largely unscathed. Key Note estimates that the UK contraception market grew by 14% between 2006 and 2010, to a total of £190.9m. The hormone-based products sector performed best in this market, growing by 27.2% over the review period, to reach £109.2m in 2010.
Intra-uterine products, while still a relatively small market, also saw significant growth of almost 20% between 2006 and 2010. By contrast, both barrier products, including condoms, and other methods, such as spermicides, saw their market value decline, the latter by nearly 20% over the review period. Although demand for condoms was waning for a number of years, they regained some of their popularity in 2009 and 2010. Condom usage has caught up with contraceptive pills, with roughly an equal percentage of women under 50 using the condom as a birth-control method as those using contraceptive pills.
In the long term, the ageing of the UK’s population is likely to have a negative impact on the contraceptive market, as younger audiences tend to have a higher usage rate of contraceptives than older age brackets. There are, however, a number of factors mitigating this trend, such as the increase in the number of women continuing to delay motherhood through contraception, as well as the increasing prevalence and awareness of sexually transmitted infections (STIs). Furthermore, both the ageing of the population and the trend for delaying motherhood are expected to boost demand for intra-uterine devices (IUDs) and intra-uterine systems (IUSs), as well as surgical contraceptive methods.
Between 2011 and 2015, the UK market for contraception is forecast to grow by 17.7% to £233.5m, with hormone-based products continuing to account for the largest sector of the market and forecast to grow by 26.8% over the 5 years.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
